The Modern Role of Beta-Blockers in Cardiovascular Medicine

The book provides a concise much-needed update of beta-blockers use cardiovascular area (particularly hypertension and heart failure). It will uncover the clinical inaccuracies of how the UK NICE Committee have "got it wrong" in their recent pronouncements on BBs and hypertension. Beta-blockers (BBs) are a large and important family of

"Knowledge desires increase - it is like fire that first must be kindled by some external agent, but which will always afterward propagate itself". Johnson, Letter to William Drummond August 13, 1776 The therapeutic effectiveness and safety of beta-adrenergic blocking drugs has been well established in patients with essential hypertension

In conjunction with the Twelfth International Congress of Gerontology, the Carl-Korth Institute for Cardiovascular Research organized an international symposium on "Beta Blockers in the Elderly." It was the intention of the Scientific Committee that during this symposium we would discuss the specific problems and therapeutic implications arising when elderly people

This is the third volume of a sub-series entitled Evaluation of Analytical Methods in Biological Systems. (The first two were Analysis of Biogenic Amines edited by G.B. Baker and R.T. Coutts, and Hazardous Metals in Human Toxicology edited by A. Vercruysse). This latest volume addresses beta-blockers - an area of

Discusses this important class of drugs, which are the subject of considerable on-going research. Includes an expanded pharmacopoeia, new chapters on physiology and health economics, and major changes in the chapters on the prevention of heart attacks and the athermatous process.